Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT5A | hg19_v2_chr17_+_40440481_40440561 | 0.02 | 9.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_50649192 Show fit | 5.72 |
ENST00000443053.2
ENST00000348721.3 |
cytokine inducible SH2-containing protein |
|
chr1_-_36937075 Show fit | 5.46 |
ENST00000464465.2
|
colony stimulating factor 3 receptor (granulocyte) |
|
chr12_-_15082050 Show fit | 5.14 |
ENST00000540097.1
|
endoplasmic reticulum protein 27 |
|
chr3_+_111260954 Show fit | 5.05 |
ENST00000283285.5
|
CD96 molecule |
|
chr4_+_155484103 Show fit | 4.79 |
ENST00000302068.4
|
fibrinogen beta chain |
|
chr4_-_155511887 Show fit | 4.61 |
ENST00000302053.3
ENST00000403106.3 |
fibrinogen alpha chain |
|
chr2_+_90198535 Show fit | 4.57 |
ENST00000390276.2
|
immunoglobulin kappa variable 1D-12 |
|
chr2_-_89292422 Show fit | 4.50 |
ENST00000495489.1
|
immunoglobulin kappa variable 1-8 |
|
chr17_-_33864772 Show fit | 4.46 |
ENST00000361112.4
|
schlafen family member 12-like |
|
chr1_-_36948879 Show fit | 4.35 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
colony stimulating factor 3 receptor (granulocyte) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 33.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 14.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.9 | 13.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.1 | 12.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 11.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 11.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 10.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.3 | 9.8 | GO:0097186 | amelogenesis(GO:0097186) |
1.6 | 9.5 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.7 | 8.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 28.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 22.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 20.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 16.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 14.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
1.0 | 13.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 9.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 8.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 8.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 7.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 37.0 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 13.0 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 10.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 10.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
2.0 | 9.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 9.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 7.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 7.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 7.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 6.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 22.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 14.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 14.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 11.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 10.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 9.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 8.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 8.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 7.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 6.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 51.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 12.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 9.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 9.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 8.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 8.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 8.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 7.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 7.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 7.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |